1,112 results on '"Hide, Michihiro"'
Search Results
2. Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan
3. Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus
4. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
5. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
6. Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial
7. A Staphylococcus epidermidis strain inhibits the uptake of Staphylococcus aureus derived from atopic dermatitis skin into the keratinocytes
8. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
9. Analysis of questionnaire survey to determine worldwide trends in prescriptions of biologics for the treatment of unresponsive chronic urticaria
10. Efficacy and safety of omalizumab in adult patients with wheat-dependent exercise-induced anaphylaxis: Reduction of in vitro basophil activation and allergic reaction to wheat
11. Efficacy, pharmacokinetics, and safety of subcutaneous C1-esterase inhibitor as prophylaxis in Japanese patients with hereditary angioedema: Results of a Phase 3 study
12. Epidemiology, Management, and Treatment Access of Hereditary Angioedema in the Asia Pacific Region: Outcomes From an International Survey
13. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
14. Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
15. The Bruton’s Tyrosine Kinase Inhibitor Remibrutinib Exhibits No Impact on Serum Immunoglobulin Levels: Insights from Chronic Spontaneous Urticaria (P10-6.018)
16. Safety of Remibrutinib Across Immune-mediated Diseases Supports Development in Multiple Sclerosis (P8-6.015)
17. Survey of hereditary angioedema episodes and quality of life impairment through a patient-participatory registry
18. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors
19. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria
20. Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021
21. Clinical and histological characterization of transient dermal pain triggered by sweating stimuli
22. A novel detection method for cross-linking of IgE-receptors by autoantibodies in chronic spontaneous urticaria
23. Dupilumab Reduces Disease Activity in Patients with Chronic Spontaneous Urticaria: LIBERTY-CSU CUPID Study A
24. Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies
25. CRUSE®—An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria
26. Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma
27. A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)
28. The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells
29. Gender disparities in academic dermatology in Japan: Results from the first national survey
30. The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey
31. Survey of actual conditions of erythema marginatum as a prodromal symptom in Japanese patients with hereditary angioedema
32. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks
33. Recurrent Wheals When He Exercised
34. Complicated cutaneous leishmaniasis caused by an imported case of Leishmania tropica in Japan: a case report
35. The practice of active patient involvement in rare disease research using ICT: experiences and lessons from the RUDY JAPAN project
36. Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosis
37. Japanese guidelines for atopic dermatitis 2020
38. Roles of omalizumab in various allergic diseases
39. Type-I-hypersensitivity to 15 kDa, 28 kDa and 54 kDa proteins in vitellogenin specific to Gadus chalcogrammus roe
40. Clinical utility of the basophil activation test in the diagnosis of sweat allergy
41. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study
42. Management of urticarial vasculitis: A worldwide physician perspective
43. Decreased intracellular histamine concentration and basophil activation in anaphylaxis
44. Pathophysiological Mechanisms of the Onset, Development, and Disappearance Phases of Skin Eruptions in Chronic Spontaneous Urticaria
45. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
46. A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative
47. HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy
48. Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
49. Staphylococcus aureus in atopic dermatitis: Strain-specific cell wall proteins and skin immunity
50. Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.